| Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer A Bardelli, S Corso, A Bertotti, S Hobor, E Valtorta, G Siravegna, ... Cancer discovery 3 (6), 658-673, 2013 | 696 | 2013 |
| The semaphorin 4D receptor controls invasive growth by coupling with Met S Giordano, S Corso, P Conrotto, S Artigiani, G Gilestro, D Barberis, ... Nature cell biology 4 (9), 720-724, 2002 | 545 | 2002 |
| Cancer therapy: can the challenge be MET? S Corso, PM Comoglio, S Giordano Trends in molecular medicine 11 (6), 284-292, 2005 | 338 | 2005 |
| Sema4D induces angiogenesis through Met recruitment by Plexin B1 P Conrotto, D Valdembri, S Corso, G Serini, L Tamagnone, PM Comoglio, ... Blood 105 (11), 4321-4329, 2005 | 319 | 2005 |
| Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages JR Sierra, S Corso, L Caione, V Cepero, P Conrotto, A Cignetti, ... The Journal of experimental medicine 205 (7), 1673-1685, 2008 | 314 | 2008 |
| Interplay between scatter factor receptors and B plexins controls invasive growth P Conrotto, S Corso, S Gamberini, PM Comoglio, S Giordano Oncogene 23 (30), 5131-5137, 2004 | 230 | 2004 |
| Increased lactate secretion by cancer cells sustains non-cell-autonomous adaptive resistance to MET and EGFR targeted therapies M Apicella, E Giannoni, S Fiore, KJ Ferrari, D Fernández-Pérez, C Isella, ... Cell metabolism 28 (6), 848-865. e6, 2018 | 224 | 2018 |
| MicroRNAs impair MET-mediated invasive growth C Migliore, A Petrelli, E Ghiso, S Corso, L Capparuccia, A Eramo, ... Cancer research 68 (24), 10128-10136, 2008 | 215 | 2008 |
| Hepatocyte growth factor and its receptor are required for malaria infection M Carrolo, S Giordano, L Cabrita-Santos, S Corso, AM Vigário, S Silva, ... Nature medicine 9 (11), 1363-1369, 2003 | 210 | 2003 |
| Silencing the MET oncogene leads to regression of experimental tumors and metastases S Corso, C Migliore, E Ghiso, G De Rosa, PM Comoglio, S Giordano Oncogene 27 (5), 684-693, 2008 | 193 | 2008 |
| MET and KRAS Gene Amplification Mediates Acquired Resistance to MET Tyrosine Kinase Inhibitors V Cepero, JR Sierra, S Corso, E Ghiso, L Casorzo, T Perera, ... Cancer research 70 (19), 7580-7590, 2010 | 179 | 2010 |
| Defective ubiquitinylation of EGFR mutants of lung cancer confers prolonged signaling K Shtiegman, BS Kochupurakkal, Y Zwang, G Pines, A Starr, A Vexler, ... Oncogene 26 (49), 6968-6978, 2007 | 174 | 2007 |
| MET Overexpression Turns Human Primary Osteoblasts into Osteosarcomas S Patane, S Avnet, N Coltella, B Costa, S Sponza, M Olivero, E Vigna, ... Cancer research 66 (9), 4750-4757, 2006 | 160 | 2006 |
| Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts XY Woo, J Giordano, A Srivastava, ZM Zhao, MW Lloyd, R de Bruijn, ... Nature genetics 53 (1), 86-99, 2021 | 153 | 2021 |
| Pro-metastatic signaling by c-Met through RAC-1 and reactive oxygen species (ROS) D Ferraro, S Corso, E Fasano, E Panieri, R Santangelo, S Borrello, ... Oncogene 25 (26), 3689-3698, 2006 | 147 | 2006 |
| Enhanced c-Met activity promotes G-CSF–induced mobilization of hematopoietic progenitor cells via ROS signaling M Tesio, K Golan, S Corso, S Giordano, A Schajnovitz, Y Vagima, ... Blood, The Journal of the American Society of Hematology 117 (2), 419-428, 2011 | 142 | 2011 |
| Plexin signaling hampers integrin‐based adhesion, leading to Rho‐kinase independent cell rounding, and inhibiting lamellipodia extension and cell motility D Barberis, S Artigiani, A Casazza, S Corso, S Giordano, CA Love, ... The FASEB journal 18 (3), 592-594, 2004 | 138 | 2004 |
| Targeted therapies for gastric cancer: failures and hopes from clinical trials M Apicella, S Corso, S Giordano Oncotarget 8 (34), 57654, 2017 | 137 | 2017 |
| HGF/MET signalling protects Plasmodium‐infected host cells from apoptosis P Leirião, SS Albuquerque, S Corso, GJ Van Gemert, RW Sauerwein, ... Cellular microbiology 7 (4), 603-609, 2005 | 136 | 2005 |
| Microsatellite instability in Gastric Cancer: Between lights and shadows E Puliga, S Corso, F Pietrantonio, S Giordano Cancer treatment reviews 95, 102175, 2021 | 135 | 2021 |
